Change over period: —
NSE · SUMICHEM
SUMICHEM
-40.8% from the 52-week high · +6.5% above the low
Sumitomo Chemical India Ltd. engages in the manufacture and sale of agricultural and household insecticides and animal nutrition products. The company is headquartered in Mumbai, Maharashtra and currently employs 1,642 full-time employees. The company went IPO on 2020-01-27. The firm manufactures, imports and markets products for crop protection, grain fumigation, rodent control, bio pesticides, environmental health, professional pest control and feed additive. The company is primarily engaged in manufacturing and sales of household insecticides, agricultural pesticides, public health insecticides and animal nutrition products. The company operates two segments, namely Agro Chemicals and Others (environmental health division and animal nutrition division). Its product range comprises of chemistry sourced from its parent company, Sumitomo Chemical Company and biological products sourced from United States-based subsidiary, Valent Biosciences LLC, which is engaged in producing a range of naturally occurring pesticides and plant growth regulators. The company also produces various technical grade pesticides in its manufacturing units with indigenous research and development (R&D) facility.
The short version. SUMICHEM reported revenue of ₹907 crore for Sep 2026, down 2.5% from a year earlier. Net profit was ₹157 crore (down 11.8% year on year). Return on equity was 16.0% in Mar 2026. Promoter holding was 75.0% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
SUMICHEM trades 40.8% below its 52-week high and 6.5% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹907 cr.
Sep 2026 net profit of ₹157 cr.
1.8 pts lower than a year earlier.
Revenue compounded at -1.6% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 907 | 1063 | 684 | 568 | 930 | 1057 | 679 | 642 |
| Net profit | 157 | 215 | 111 | 76 | 178 | 178 | 100 | 87 |
| Net margin % | 17.3 | 20.2 | 16.3 | 13.3 | 19.1 | 16.9 | 14.7 | 13.5 |
| EPS (₹) | 3.15 | 4.3 | 2.23 | 1.52 | 3.56 | 3.57 | 2.0 | 1.74 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|---|
| Revenue | 3238 | 3149 | 2844 | 3511 | 3065 | 2645 | 2425 |
| Net profit | 543 | 505 | 370 | 502 | 424 | 345 | 205 |
| Net margin % | 16.8 | 16.1 | 13.0 | 14.3 | 13.8 | 13.1 | 8.4 |
| EPS (₹) | 10.88 | 10.13 | 7.4 | 10.06 | 8.49 | 6.92 | 4.1 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 16.0% in Mar 2026; debt to equity is 0.00.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 16.0 | 17.4 | 15.1 | 21.1 |
| Return on capital % | 21.0 | 22.9 | 20.2 | 27.1 |
| EBITDA margin % | 23.7 | 23.0 | 19.4 | 20.0 |
| Net margin % | 16.0 | 15.5 | 12.6 | 14.1 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | -1.6% | 4.9% |
| Profit CAGR | 2.6% | 9.5% |
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
Down 0.7 pts over 8 quarters.
Up 2.73 pts over 8 quarters.
+24 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 75.0 | 75.0 | 75.0 | 75.0 | 75.0 | 75.0 | 75.0 | 75.0 | 0.0 |
| FII | 3.59 | 3.63 | 3.65 | 3.65 | 3.37 | 3.4 | 3.02 | 2.89 | -0.7 |
| DII | 6.96 | 8.14 | 8.15 | 8.47 | 8.65 | 8.98 | 9.33 | 9.69 | +2.73 |
| Public | 14.45 | 13.23 | 13.2 | 12.88 | 12.97 | 12.61 | 12.65 | 12.42 | -2.03 |
Mutual fund holdings · Oct 2026
89 schemes hold this stock
65 the month before.
- quant Commodities Fund4.1% of NAV
- quant Manufacturing Fund3.03% of NAV
- Baroda BNP Paribas Manufacturing Fund1.93% of NAV
- TATA RESOURCES & ENERGY FUND1.25% of NAV
- ADITYA BIRLA SUN LIFE BAL BHAVISHYA YOJNA1.21% of NAV
- The Wealth Company Large & Mid Cap Fund1.18% of NAV
- Kotak Nifty Chemicals ETF1.17% of NAV
- Groww Nifty Chemicals ETF1.17% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for SUMICHEM are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Fertilizers & Agrochemicals stocks
Quick answers
Common questions about SUMICHEM
What is the SUMICHEM share price?
SUMICHEM (SUMICHEM) last closed at ₹344.15, up 2.96% on the day. Its 52-week range is ₹313.90 to ₹564.95.
What is the market cap of SUMICHEM?
SUMICHEM has a market capitalisation of about ₹16,632 crore. Its price-to-earnings ratio is 30.0.
How are SUMICHEM's latest results?
SUMICHEM reported revenue of ₹907 crore for Sep 2026, down 2.5% from a year earlier. Net profit was ₹157 crore (down 11.8% year on year). Return on equity was 16.0% in Mar 2026. Promoter holding was 75.0% in Sep 2026, up 0.00 points over 8 quarters.
Who owns SUMICHEM?
As of Sep 2026, shareholding was: Promoter 75.0%, FII 2.89%, DII 9.69%, Public 12.42%.
How many mutual funds hold SUMICHEM?
89 mutual fund schemes held SUMICHEM in October 2026. That compares with 65 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 25 Jul 2025 · Final Dividend - Rs. 1.2
- 19 Jul 2024 · Final Dividend - Rs. 0.9
- 14 Feb 2024 · Special Dividend - Rs. 5
- 21 Jul 2023 · Final Dividend - Rs. 1.2
- 21 Jul 2022 · Final Dividend - Rs. 1
- 22 Jul 2021 · Final Dividend - Rs. 0.8
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.